Douglas Boettner

About Douglas Boettner

Broad experience across each layer of drug development from early development, clinical development and life cycle management. Skilled at managing projects with national and international scope, ensuring stakeholder engagement to build better solutions. Most recently, I am supporting our Anti-infective and Respiratory pipeline including 6 GSK molecules across numerous trials. In this role I have worked broadly within my organization to ensure alignment, appropriate communication and timely engagement with US experts to meet clinical, scientific and regulatory demands. Strengths: Relationship development, insight generation, scientific strategy, critical analysis, writing, public speaking, project management and education.

Experience

1. Medical Lead Anti-infectives & Respiratory (Air) Pipeline

   GSK

   Jun 2023 — Present

   US anti-infectives and respiratory diseases medical pipeline l head leading team supporting asset advancement from early-stage research through to commercial launch. Working within the matrix to navigate brand narratives, meet governance steps, identify solutions to fill strategic gaps and ultimately prepare for launch. The current AIR pipeline includes 10 assets covering 15 disease areas and valued over $20 billion in forecasted PYS. Pipeline successes included launch of Gepotidacin, Depemokimab, and FDA submission of Tebipenem.

Education

• University of Virginia

  Doctor of Philosophy (Ph.D.)

• University of Cincinnati

  Bachelor's Degree